Literature DB >> 3084507

Addisonian crisis after thyroid replacement.

P F Banitt, A K Munson.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 3084507

Source DB:  PubMed          Journal:  Hosp Pract (Off Ed)        ISSN： 8750-2836


× No keyword cloud information.
  8 in total

1.  Addison's disease. Adrenal insufficiency should be excluded before thyroxine replacement is started.

Authors:  I A Osman; P Leslie
Journal:  BMJ       Date:  1996-08-17

2.  Predicting onset of secondary-progressive multiple sclerosis using genetic and non-genetic factors.

Authors:  Elina Misicka; Corriene Sept; Farren B S Briggs
Journal:  J Neurol       Date:  2020-04-24       Impact factor: 4.849

3.  Increased sensitivity to thyroid hormone replacement therapy followed by hyponatremia and eosinophilia in a patient with long-standing young-onset primary hypothyroidism.

Authors:  M Fujikawa; K Okamura; K Sato; T Mizokami; M Shiratsuchi; M Fujishima
Journal:  J Endocrinol Invest       Date:  1999-06       Impact factor: 4.256

Review 4.  "Glandular intoxication" following emergent tracheotomy during transsphenoidal surgery for acromegaly: Cushing's 1910 unrecognized case of thyroid storm?

Authors:  Courtney Pendleton; Nestoras Mathioudakis; Roberto Salvatori; Alfredo Quinones-Hinojosa
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

5.  Dyschromatopsia in multiple sclerosis reflects diffuse chronic neurodegeneration beyond anatomical landmarks.

Authors:  Antonio Barreiro-González; Maria T Sanz; Sara Carratalà-Boscà; Francisco Pérez-Miralles; Carmen Alcalá; Enrique España-Gregori; Bonaventura Casanova
Journal:  Acta Neurol Belg       Date:  2020-10-12       Impact factor: 2.396

Review 6.  Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints.

Authors:  Lee-Shing Chang; Romualdo Barroso-Sousa; Sara M Tolaney; F Stephen Hodi; Ursula B Kaiser; Le Min
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

Review 7.  Apparent changes in the epidemiology and severity of multiple sclerosis.

Authors:  Nils Koch-Henriksen; Melinda Magyari
Journal:  Nat Rev Neurol       Date:  2021-09-28       Impact factor: 42.937

Review 8.  The Development of Cladribine Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review.

Authors:  Kottil Rammohan; Patricia K Coyle; Elke Sylvester; Andrew Galazka; Fernando Dangond; Megan Grosso; Thomas P Leist
Journal:  Drugs       Date:  2020-12       Impact factor: 9.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.